Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Kang'ao Pharmaceutical Research Institute is a specialized contract research organization (CRO) and pharmaceutical R&D center located in Chengdu, China. Founded in 2003, the institute focuses on the development of small molecule drugs, encompassing drug design, chemical synthesis, and formulation research. The company provides comprehensive technical services to the pharmaceutical industry, including generic drug consistency evaluation, process optimization, and quality standard establishment. Operating out of the Chengdu High-tech Zone, it has established a reputation for bridging the gap between laboratory-scale discovery and commercial-scale manufacturing. Its expertise spans several therapeutic areas, including cardiovascular health, oncology, and anti-infectives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Kang'ao Pharmaceutical Research Institute.